Phenotypic and Genetic Features that Differ Between Hereditary and Sporadic Melanoma: Results of a Preliminary Study from a Single Center from Turkey

Phenotypic and Genetic Features that Differ Between Hereditary and Sporadic Melanoma: Results of a Preliminary Study from a Single Center from Turkey

Authors

  • Aysel Çakır Hacettepe University Faculty of Medicine, Department of Dermatology and Venerology, Ankara, Turkey
  • Gonca Elcin Hacettepe University Faculty of Medicine, Department of Dermatology and Venerology, Ankara, Turkey
  • Saadettin Kilickap Hacettepe University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey
  • Özay Gököz Hacettepe University Faculty of Medicine, Department of Medical Pathology, Ankara, Turkey
  • Zihni Ekim Taskiran Hacettepe University Faculty of Medicine, Department of Medical Genetics, Ankara, Turkey
  • İsmail Celik Hacettepe University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey

Keywords:

melanoma, hereditary melanoma, sporadic melanoma, cdkn2a, mc1r

Abstract

Introduction: We have observed that most cutaneous melanoma patients under our supervision lack characteristic phenotypical features for melanoma. In contrast; history of cancers other than melanoma and age at onset before 50 were common. This observation was in favour of hereditary melanoma.

Objectives: The aim of this study was to search for the phenotypical and genetic features that distinguish between sporadic and hereditary melanomas.

Methods: All cutaneous melanoma patients (n=43) under our supervision were evaluated dermatologically in detail for phenotypical features. CDKN2A and MC1R mutations were detected with Sanger sequencing method. Assignment to hereditary and sporadic groups was done according to the "melanoma cancer syndrome assessment tool". Patients who were diagnosed before 50 years of age were also assigned to the hereditary melanoma group.

Results: Concerning phenotypic features, fair eye colour was statistically significantly higher in the sporadic group (p=0.000). CDKN2A was detected in only 1 patient in the hereditary group. MC1R mutations were found in 12 out of 13 (92.3%) in the hereditary melanoma group with a score ≥3 points, 13 out of 18 (72.2%) in the early onset group and 5 out of 12 (41.7%) in the sporadic melanoma group (p=0.024).

Discussion: Incidence of CDKN2A mutations in our hereditary group is in accordance with reported incidences from Mediterranean countries. The difference between the hereditary and sporadic melanoma groups in terms of MC1R mutations supports the idea that MC1R genetic testing might help to determine patients with higher risk for hereditary melanoma.

 

References

Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96. DOI: 10.3322/CA.2007.0010. PMID: 18287387.

Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41(1):45-60. DOI: 10.1016/j.ejca.2004.10.016. PMID: 15617990.

Leachman SA, Carucci J, Kohlmann W, et al. Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol. 2009;61(4):677.e1-E14. DOI: 10.1016/j.jaad.2009.03.016. PMID: 19751883. PMCID: PMC3307795.

Goldstein AM, Chan M, Harland M, et al. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res. 2006;66(20):9818-9828. DOI: 10.1158/0008-5472.CAN-06-0494. PMID: 17047042.

Meyle KD, Guldberg P. Genetic risk factors for melanoma. Hum Genet. 2009;126(4):499-510. dDOI: 10.1007/s00439-009-0715-9. PMID: 19585149.

Raimondi S, Sera F, Gandini S, et al. MC1R variants, melanoma and red hair color phenotype: A meta-analysis. Int J Cancer. 2008;122(12):2753-2760. DOI: 10.1002/ijc.23396. PMID: 18366057.

Ward KA, Lazovich D, Hordinsky MK. Germline melanoma susceptibility and prognostic genes: A review of the literature. J Am Acad Dermatol. 2012;67(5):1055-1067. DOI: 10.1016/j.jaad.2012.02.042. PMID: 22583682.

Leachman SA, Lucero OM, Sampson JE, et al. Identification, genetic testing, and management of hereditary melanoma. Cancer Metastasis Rev. 2017;36(1):77-90. DOI: 10.1007/s10555-017-9661-5. PMID: 28283772. PMCID: PMC5385190.

Forsea AM, Del Marmol V, De Vries E, Bailey EE, Geller AC. Melanoma incidence and mortality in Europe: New estimates, persistent disparities. Br J Dermatol. 2012;167(5):1124-1130. DOI: 10.1111/j.1365-2133.2012.11125.x. PMID: 22759278.

Turkish Ministry of Health-public health institution. Cancer Statistics of Turkey (Türki̇ye kanser i̇stati̇sti̇kleri̇). 2017:1-48. https://hsgm.saglik.gov.tr/tr/kanser-istatistikleri/yillar/2017-turkiye-kanser-i-statistikleri.html

Goldstein AM, Chan M, Harland M, et al. Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents. J Med Genet. 2007;44(2):99-106. DOI: 10.1136/jmg.2006.043802. PMID: 16905682. PMCID: PMC2598064.

Landi MT, Kanetsky PA, Tsang S, et al. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a mediterranean population. J Natl Cancer Inst. 2005;97(13):998-1007. DOI: 10.1093/jnci/dji176. PMID: 15998953.

Pellegrini C, Maturo MG, Martorelli C, et al. Characterization of melanoma susceptibility genes in high-risk patients from Central Italy. Melanoma Res. 2017;27(3):258-267. DOI: 10.1097/CMR.0000000000000323. PMID: 28146043. PMCID: PMC7050442.

De Torre C, Garcia-Casado Z, Martínez-Escribano JA, et al. Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain. Melanoma Res. 2010;20(4):342-348. DOI: 10.1097/CMR.0b013e32833b159d. PMID: 20539244.

Huertas C, Garcia-Casado Z, Bañuls J, et al. Characteristics of Familial Melanoma in Valencia, Spain, Based on the Presence of CDKN2A Mutations and MC1R Variants. Acta Derm Venereol. 2018;98(5):512-516. DOI: 10.2340/00015555-2898. PMID: 29405243.

Stratigos AJ, Dimisianos G, Nikolaou V, et al. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern european population. J Invest Dermatol. 2006;126(8):1842-1849. DOI: 10.1038/sj.jid.5700292. PMID: 16601669.

Gerstenblith MR, Goldstein AM, Fargnoli MC, Peris K, Landi MT. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat. 2007;28(5):495-505. DOI: 10.1002/humu.20476. PMID: 17279550.

Casula M, Muggiano A, Cossu A, et al. Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy. BMC Cancer. 2009;9:352. DOI: 10.1186/1471-2407-9-352. PMID: 19799798. PMCID: PMC2763007.

Koulermou G, Shammas C, Vassiliou A, et al. CDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma. J Genet. 2017;96(1):155-160. DOI: 10.1007/s12041-017-0742-6. PMID: 28360400.

Müller C, Wendt J, Rauscher S, et al. Characterization of patients at high risk of melanoma in Austria. Br J Dermatol. 2016;174(6):1308-1317. DOI: 10.1111/bjd.14407. PMID: 26800492.

Downloads

Published

2023-07-31

Issue

Section

Original Article

How to Cite

1.
Çakır A, Elcin G, Kilickap S, Gököz Özay, Taskiran ZE, Celik İsmail. Phenotypic and Genetic Features that Differ Between Hereditary and Sporadic Melanoma: Results of a Preliminary Study from a Single Center from Turkey. Dermatol Pract Concept. 2023;13(3):e2023146. doi:10.5826/dpc.1303a146

Share